Zobrazeno 1 - 1
of 1
pro vyhledávání: ''
Publikováno v:
New England Journal of Medicine. 287:75-78
A review of abstracts and papers reporting clinical trials of new anticancer agents reveals that only a small percentage have been controlled. Arguments against employing randomized controls in such trials are understandable but hardly valid at the p